KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $1.3 billion.

  • Medtronic's Shares Outstanding (Weighted Average) fell 51.22% to $1.3 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $1.3 billion, marking a year-over-year decrease of 51.22%. This contributed to the annual value of $1.3 billion for FY2025, which is 317.09% down from last year.
  • Medtronic's Shares Outstanding (Weighted Average) amounted to $1.3 billion in Q4 2025, which was down 51.22% from $1.3 billion recorded in Q3 2025.
  • Medtronic's 5-year Shares Outstanding (Weighted Average) high stood at $1.3 billion for Q4 2021, and its period low was $1.3 billion during Q3 2025.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $1.3 billion (2023), whereas its average is $1.3 billion.
  • As far as peak fluctuations go, Medtronic's Shares Outstanding (Weighted Average) skyrocketed by 31.33% in 2021, and later crashed by 326.29% in 2025.
  • Medtronic's Shares Outstanding (Weighted Average) (Quarter) stood at $1.3 billion in 2021, then fell by 1.17% to $1.3 billion in 2022, then increased by 0.07% to $1.3 billion in 2023, then fell by 3.13% to $1.3 billion in 2024, then decreased by 0.51% to $1.3 billion in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $1.3 billion for Q4 2025, versus $1.3 billion for Q3 2025 and $1.3 billion for Q2 2025.